AstraZeneca is a company with a turbulent history but, for now, a promising future. We take a look at the company's story, from its creation as a merger of two equals, to its recent major ...

Eli Lilly bets big on weight-loss pill with $550 million inventory stockpile Healthcare & Pharmaceuticalscategory· February 20, 2025 AstraZeneca will buy longtime partner FibroGen's China unit ...

AstraZeneca's lengthy and turbulent development of CTLA4 inhibitor tremelimumab has at least led to a regulatory approval as part of a combination therapy for advanced liver cancer.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

AstraZeneca Pharma India Ltd., incorporated in the year 1979, is a Mid Cap company (having a market cap of Rs 17,439.50 Crore) operating in Pharmaceuticals sector. AstraZeneca Pharma India Ltd. key ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Pre-Market: 9:01:21 a.m. EST ...

After hours: 7:50:59 pm GMT-5 ...